CARR vs SUPN · P/E 43, rev $21.75B vs rev $426.8M
Carrier Global Corp (CARR) versus Supernus Pharmaceuticals Inc (SUPN) — a side-by-side from cached financials, not a winner call.
Carrier Global Corp (CARR) is a building products & equipment company listed on US.
Supernus Pharmaceuticals Inc (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CARR revenue for 2025-12-31 was $21.75B. Net income was $1.48B. Revenue was up 322.4% from 2024-12-31 to 2025-12-31. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
Latest reported SUPN revenue for 2026-06-30 was $426.8M. Net income was -$60.7M. SUPN currently screens at market cap $2.53B.
CARR currently screens at market cap $53.05B and trailing P/E 42.6. SUPN currently screens at market cap $2.53B.
Not investment advice. Open the CARR and SUPN stock pages for the full models.
Not investment advice.